ethosuximide 50 MG/ML Oral Solution
- RxCUI
- 251322
- RxNorm name
- ethosuximide 50 MG/ML Oral Solution
- Display name
- ethosuximide 50 MG/ML Oral Solution
- Full name
- ethosuximide 50 MG/ML Oral Solution
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ethosuximide | ETHOSUXIMIDE | Mylan Pharmaceuticals Inc. | 19c924c2-f558-4c78-9277-2d7e0df2f505 | 2026-07-24 | Warnings, Adverse reactions | 251322 |
| Ethosuximide | ETHOSUXIMIDE | Chartwell Governmental & Specialty RX, LLC. | a825265d-ace9-4463-a16d-f6d5e1e31188 | 2026-06-11 | Warnings, Adverse reactions | 251322 |
| Ethosuximide | ETHOSUXIMIDE | Chartwell RX, LLC | 9812840a-004d-46fa-8414-7d04a384e06a | 2026-05-28 | Warnings, Adverse reactions | 251322 |
| ETHOSUXIMIDE | ETHOSUXIMIDE | PAI Holdings, LLC dba PAI Pharma | 8a5cc930-0b36-48a8-9ad0-de633b208742 | 2025-10-17 | Warnings, Adverse reactions | 251322 |
| Zarontin | ETHOSUXIMIDE | Parke-Davis Div of Pfizer Inc | 7bf3e616-45e8-4469-a75d-4d824ce951ea | 2023-07-13 | Warnings, Adverse reactions | 251322 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7bf3e616-45e8-4469-a75d-4d824ce951ea | ethosuximide 250 MG per 5 ML Oral Solution | SY | 25 | Zarontin ® (Ethosuximide) ORAL SOLUTION | 20230713 |
| 7bf3e616-45e8-4469-a75d-4d824ce951ea | ethosuximide 250 MG in 5 mL Oral Solution | PSN | 25 | Zarontin ® (Ethosuximide) ORAL SOLUTION | 20230713 |
| 7bf3e616-45e8-4469-a75d-4d824ce951ea | ethosuximide 50 MG/ML Oral Solution | SCD | 25 | Zarontin ® (Ethosuximide) ORAL SOLUTION | 20230713 |
| 8a5cc930-0b36-48a8-9ad0-de633b208742 | ethosuximide 250 MG in 5 mL Oral Solution | PSN | 17 | Ethosuximide Oral Solution USP | 20251017 |
| 8a5cc930-0b36-48a8-9ad0-de633b208742 | ethosuximide 250 MG per 5 ML Oral Solution | SY | 17 | Ethosuximide Oral Solution USP | 20251017 |
| 8a5cc930-0b36-48a8-9ad0-de633b208742 | ethosuximide 50 MG/ML Oral Solution | SCD | 17 | Ethosuximide Oral Solution USP | 20251017 |
| 19c924c2-f558-4c78-9277-2d7e0df2f505 | ethosuximide 250 MG per 5 ML Oral Solution | SY | 16 | Ethosuximide ORAL SOLUTION | 20250725 |
| 19c924c2-f558-4c78-9277-2d7e0df2f505 | ethosuximide 50 MG/ML Oral Solution | SCD | 16 | Ethosuximide ORAL SOLUTION | 20250725 |
| 19c924c2-f558-4c78-9277-2d7e0df2f505 | ethosuximide 250 MG in 5 mL Oral Solution | PSN | 16 | Ethosuximide ORAL SOLUTION | 20250725 |
| 9812840a-004d-46fa-8414-7d04a384e06a | ethosuximide 250 MG in 5 mL Oral Solution | PSN | 1 | Ethosuximide Oral Solution, USP 250 mg per 5 mL | 20260528 |
| 9812840a-004d-46fa-8414-7d04a384e06a | ethosuximide 50 MG/ML Oral Solution | SCD | 1 | Ethosuximide Oral Solution, USP 250 mg per 5 mL | 20260528 |
| 9812840a-004d-46fa-8414-7d04a384e06a | ethosuximide 250 MG per 5 ML Oral Solution | SY | 1 | Ethosuximide Oral Solution, USP 250 mg per 5 mL | 20260528 |